Do analysts recommend TMDIF or ITOC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Itonic 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, TMDIF or ITOC?

Titan Medical has higher revenue and earnings than Itonic. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Titan Medical $17.63M 1.16 $6.95M $0.05 3.60 Itonic $523.03K 9.95 -$5.10M N/A N/A

Is TMDIF or ITOC more profitable?

Itonic's return on equity of 0.00% beat Titan Medical's return on equity. Company Net Margins Return on Equity Return on Assets Titan Medical N/A -82.31% -51.47% Itonic N/A N/A N/A

Do analysts prefer ICU or ITOC?

SeaStar Medical currently has a consensus price target of $8.00, indicating a potential upside of 62.60%. Given SeaStar Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe SeaStar Medical is more favorable than Itonic. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Itonic 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, ICU or ITOC?

Itonic has lower revenue, but higher earnings than SeaStar Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SeaStar Medical $1.23M 16.00 -$12.15M -$4.80 N/A Itonic $523.03K 9.95 -$5.10M N/A N/A

Do analysts rate ITOC or IRIX?

IRIDEX has a consensus target price of $3.00, suggesting a potential upside of 165.49%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts clearly believe IRIDEX is more favorable than Itonic. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Itonic 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation & earnings, ITOC or IRIX?

IRIDEX has higher revenue and earnings than Itonic. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Itonic $523.03K 9.95 -$5.10M N/A N/A IRIDEX $52.67M 0.37 -$4.44M -$0.19 N/A

Is ITOC or IRIX more profitable?

Itonic has a net margin of 0.00% compared to IRIDEX's net margin of -6.23%. Company Net Margins Return on Equity Return on Assets Itonic N/A N/A N/A IRIDEX -6.23% N/A -11.16%

Do analysts prefer ITOC or ICCM?

IceCure Medical has a consensus price target of $62.70, suggesting a potential upside of 1,069.78%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than Itonic. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Itonic 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 IceCure Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has stronger earnings & valuation, ITOC or ICCM?

Itonic has higher earnings, but lower revenue than IceCure Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Itonic $523.03K 9.95 -$5.10M N/A N/A IceCure Medical $3.38M 5.44 -$15.06M -$7.21 N/A

Is ITOC or ICCM more profitable?

Itonic has a net margin of 0.00% compared to IceCure Medical's net margin of -441.60%. Itonic's return on equity of 0.00% beat IceCure Medical's return on equity. Company Net Margins Return on Equity Return on Assets Itonic N/A N/A N/A IceCure Medical -441.60% -211.73% -119.13%

Do analysts rate HIND or ITOC?

Vyome presently has a consensus target price of $15.00, suggesting a potential upside of 552.17%. Given Vyome's stronger consensus rating and higher possible upside, equities analysts clearly believe Vyome is more favorable than Itonic. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vyome 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Itonic 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, HIND or ITOC?

Itonic has higher revenue and earnings than Vyome. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vyome $320K 50.46 -$10.26M -$12.27 N/A Itonic $523.03K 9.95 -$5.10M N/A N/A

Is HIND or ITOC more profitable?

Itonic's return on equity of 0.00% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Vyome N/A -203.92% -134.16% Itonic N/A N/A N/A

Itonic (ITOC) Competitors

$0.31 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$0.32 +0.01 (+3.24%)

As of 07/2/2026 07:59 PM Eastern

Compare

ITOC vs. TMDIF, ICU, IRIX, ICCM, and HIND

Should you buy Itonic stock or one of its competitors? MarketBeat compares Itonic with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Itonic include Titan Medical (TMDIF), SeaStar Medical (ICU), IRIDEX (IRIX), IceCure Medical (ICCM), and Vyome (HIND). These companies are all part of the "medical equipment" industry.

How does Itonic compare to Titan Medical?

Titan Medical (NASDAQ:TMDIF) and Itonic (NASDAQ:ITOC) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market. Comparatively, Itonic has a beta of 2.75, indicating that its share price is 175% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

0.0% of Titan Medical shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Titan Medical's average media sentiment score of 0.00 equaled Itonic'saverage media sentiment score.

Company	Overall Sentiment
Titan Medical	Neutral
Itonic	Neutral

Titan Medical has higher revenue and earnings than Itonic.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	1.16	$6.95M	$0.05	3.60
Itonic	$523.03K	9.95	-$5.10M	N/A	N/A

Itonic's return on equity of 0.00% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Itonic	N/A	N/A	N/A

Summary

Itonic beats Titan Medical on 5 of the 9 factors compared between the two stocks.

How does Itonic compare to SeaStar Medical?

SeaStar Medical (NASDAQ:ICU) and Itonic (NASDAQ:ITOC) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

Itonic has lower revenue, but higher earnings than SeaStar Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	16.00	-$12.15M	-$4.80	N/A
Itonic	$523.03K	9.95	-$5.10M	N/A	N/A

SeaStar Medical has a beta of -1.05, meaning that its stock price is 205% less volatile than the broader market. Comparatively, Itonic has a beta of 2.75, meaning that its stock price is 175% more volatile than the broader market.

SeaStar Medical currently has a consensus price target of $8.00, indicating a potential upside of 62.60%. Given SeaStar Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe SeaStar Medical is more favorable than Itonic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, SeaStar Medical's average media sentiment score of 0.00 equaled Itonic'saverage media sentiment score.

Company	Overall Sentiment
SeaStar Medical	Neutral
Itonic	Neutral

1.7% of SeaStar Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Itonic has a net margin of 0.00% compared to SeaStar Medical's net margin of -828.62%. Itonic's return on equity of 0.00% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-828.62%	-146.29%	-96.48%
Itonic	N/A	N/A	N/A

Summary

SeaStar Medical beats Itonic on 7 of the 12 factors compared between the two stocks.

How does Itonic compare to IRIDEX?

Itonic (NASDAQ:ITOC) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.

In the previous week, IRIDEX had 1 more articles in the media than Itonic. MarketBeat recorded 1 mentions for IRIDEX and 0 mentions for Itonic. IRIDEX's average media sentiment score of 0.75 beat Itonic's score of 0.00 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Overall Sentiment
Itonic	Neutral
IRIDEX	Positive

IRIDEX has higher revenue and earnings than Itonic.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Itonic	$523.03K	9.95	-$5.10M	N/A	N/A
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A

Itonic has a beta of 2.75, indicating that its stock price is 175% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market.

Itonic has a net margin of 0.00% compared to IRIDEX's net margin of -6.23%.

Company	Net Margins	Return on Equity	Return on Assets
Itonic	N/A	N/A	N/A
IRIDEX	-6.23%	N/A	-11.16%

IRIDEX has a consensus target price of $3.00, suggesting a potential upside of 165.49%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts clearly believe IRIDEX is more favorable than Itonic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

20.1% of IRIDEX shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

IRIDEX beats Itonic on 9 of the 13 factors compared between the two stocks.

How does Itonic compare to IceCure Medical?

Itonic (NASDAQ:ITOC) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

Itonic has higher earnings, but lower revenue than IceCure Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Itonic	$523.03K	9.95	-$5.10M	N/A	N/A
IceCure Medical	$3.38M	5.44	-$15.06M	-$7.21	N/A

In the previous week, Itonic's average media sentiment score of 0.00 equaled IceCure Medical'saverage media sentiment score.

Company	Overall Sentiment
Itonic	Neutral
IceCure Medical	Neutral

Itonic has a beta of 2.75, suggesting that its share price is 175% more volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.43, suggesting that its share price is 57% less volatile than the broader market.

Itonic has a net margin of 0.00% compared to IceCure Medical's net margin of -441.60%. Itonic's return on equity of 0.00% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Itonic	N/A	N/A	N/A
IceCure Medical	-441.60%	-211.73%	-119.13%

0.6% of IceCure Medical shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

IceCure Medical has a consensus price target of $62.70, suggesting a potential upside of 1,069.78%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than Itonic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Itonic and IceCure Medical tied by winning 6 of the 12 factors compared between the two stocks.

How does Itonic compare to Vyome?

Vyome (NASDAQ:HIND) and Itonic (NASDAQ:ITOC) are both small-cap manufacturing companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

22.1% of Vyome shares are held by institutional investors. 33.0% of Vyome shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Vyome has a beta of 1.49, meaning that its stock price is 49% more volatile than the broader market. Comparatively, Itonic has a beta of 2.75, meaning that its stock price is 175% more volatile than the broader market.

In the previous week, Vyome had 2 more articles in the media than Itonic. MarketBeat recorded 2 mentions for Vyome and 0 mentions for Itonic. Vyome's average media sentiment score of 0.73 beat Itonic's score of 0.00 indicating that Vyome is being referred to more favorably in the media.

Company	Overall Sentiment
Vyome	Positive
Itonic	Neutral

Vyome presently has a consensus target price of $15.00, suggesting a potential upside of 552.17%. Given Vyome's stronger consensus rating and higher possible upside, equities analysts clearly believe Vyome is more favorable than Itonic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Itonic's return on equity of 0.00% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	N/A	-203.92%	-134.16%
Itonic	N/A	N/A	N/A

Itonic has higher revenue and earnings than Vyome.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$320K	50.46	-$10.26M	-$12.27	N/A
Itonic	$523.03K	9.95	-$5.10M	N/A	N/A

Summary

Vyome beats Itonic on 8 of the 13 factors compared between the two stocks.

Get Itonic News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITOC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ITOC vs. The Competition

Export

Metric	Itonic	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$5.20M	$3.23B	$5.20B	$12.48B
Dividend Yield	N/A	N/A	16.11%	6.52%
P/E Ratio	N/A	20.07	23.91	24.70
Price / Sales	9.95	389.38	216.83	99.49
Price / Cash	N/A	9.27	35.06	57.09
Price / Book	0.64	5.79	13.25	6.46
Net Income	-$5.10M	$7.39M	$113.80M	$337.01M
7 Day Performance	-0.29%	0.70%	0.93%	1.69%
1 Month Performance	8.96%	-0.17%	1.08%	3.81%
1 Year Performance	N/A	-38.62%	10.03%	23.90%

Itonic Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ITOC Itonic	N/A	$0.31 flat	N/A	N/A	$5.20M	$523.03K	N/A	N/A
TMDIF Titan Medical	N/A	$0.18 +9.2%	N/A	-35.8%	$20.52M	$17.63M	N/A	50
ICU SeaStar Medical	2.5374 of 5 stars	$4.92 +1.2%	$8.00 +62.6%	-8.6%	$19.68M	$1.23M	N/A	2	Gap Down High Trading Volume
IRIX IRIDEX	2.6467 of 5 stars	$1.13 -3.4%	$3.00 +165.5%	+23.4%	$19.67M	$52.67M	N/A	120	News Coverage Positive News Analyst Upgrade
ICCM IceCure Medical	3.1453 of 5 stars	$5.36 +1.5%	$62.70 +1,069.8%	-83.1%	$18.39M	$3.38M	N/A	60

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ITOC) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Itonic (ITOC) Competitors

ITOC vs. TMDIF, ICU, IRIX, ICCM, and HIND

How does Itonic compare to Titan Medical?

Summary

How does Itonic compare to SeaStar Medical?

Summary

How does Itonic compare to IRIDEX?

Summary

How does Itonic compare to IceCure Medical?

Summary

How does Itonic compare to Vyome?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITOC vs. The Competition

Itonic Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Itonic (ITOC) Competitors

ITOC vs. TMDIF, ICU, IRIX, ICCM, and HIND

How does Itonic compare to Titan Medical?

Which has more volatility & risk, TMDIF or ITOC?

Do analysts recommend TMDIF or ITOC?

Do institutionals and insiders have more ownership in TMDIF or ITOC?

Does the media favor TMDIF or ITOC?

Which has preferable earnings and valuation, TMDIF or ITOC?

Is TMDIF or ITOC more profitable?

Summary

How does Itonic compare to SeaStar Medical?

Which has higher earnings and valuation, ICU or ITOC?

Which has more volatility and risk, ICU or ITOC?

Do analysts prefer ICU or ITOC?

Does the media prefer ICU or ITOC?

Do insiders & institutionals believe in ICU or ITOC?

Is ICU or ITOC more profitable?

Summary

How does Itonic compare to IRIDEX?

Does the media favor ITOC or IRIX?

Which has preferable valuation & earnings, ITOC or IRIX?

Which has more volatility & risk, ITOC or IRIX?

Is ITOC or IRIX more profitable?

Do analysts rate ITOC or IRIX?

Do institutionals & insiders hold more shares of ITOC or IRIX?

Summary

How does Itonic compare to IceCure Medical?

Which has stronger earnings & valuation, ITOC or ICCM?

Does the media favor ITOC or ICCM?

Which has more risk & volatility, ITOC or ICCM?

Is ITOC or ICCM more profitable?

Do institutionals and insiders have more ownership in ITOC or ICCM?

Do analysts prefer ITOC or ICCM?

Summary

How does Itonic compare to Vyome?

Do institutionals & insiders have more ownership in HIND or ITOC?

Which has more risk & volatility, HIND or ITOC?

Does the media prefer HIND or ITOC?

Do analysts rate HIND or ITOC?

Is HIND or ITOC more profitable?

Which has stronger valuation and earnings, HIND or ITOC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITOC vs. The Competition

Itonic Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools